CardioMEMS™ HF System: Patient Conversation Aid
• Have NYHA Class II or III heart failure
• Have been hospitalized for heart failure in the past 12 months and/or
• Have an elevated BNP or NT/pro-BNP
More than 35,000+ patients with heart failure have received the CardioMEMS HF System1 since it was FDA approved in 2014.
The sensor has no batteries or leads and will be placed during a simple and safe procedure.
If you upload daily readings, your care team can monitor your heart failure from anywhere.
Your care team will be alerted that there are changes in your heart pressure, often before you start feeling symptoms.
In the past, a patient's condition was determined by how they felt at the time. Now, your doctor no longer has to wait for you to feel bad or for symptoms to appear, which can be too late. The CardioMEMS HF System data can indicate worsening heart failure weeks before symptoms appear and is proven to reduce heart failure hospitalizations and improve patient-reported quality of life.2
Graph adapted from Adamson PB. Pathophysiology of the transition from chronic compensated and acute decompensated heart failure:new insights from continuous monitoring devices. Current Heart Failure Reports. 2009;6:287-292
During a common surgical procedure, a tiny pressure-sensing device, about the size of a dime, is placed in your pulmonary artery (PA).
The patient electronics system is used to take daily PA pressure readings from anywhere with a connection. A reading only takes 2-3 minutes.
The system sends these readings to your care team through a secure website. Your care team reviews the readings and contacts you if any changes are needed.
• Approved in 2014, 35,000+ patients have already been implanted.
• Your care team can remotely monitor your heart's pressures from wherever you take your readings.
• The CardioMEMS HF System is proven safe and effective.
MAT-2400399 v2.0
Stay Connected